Skip to main content
  • Research article
  • Open access
  • Published:

Health care providers’ attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe



In Kenya, South Africa, and Zimbabwe, oral pre-exposure prophylaxis (PrEP) is recommended for adolescent girls and young women (AGYW) at high risk of HIV. Health providers play a critical role in the uptake and effective use of sexual and reproductive health services; however, few published studies have explored providers’ attitudes toward and experiences delivering PrEP to AGYW.


We conducted a cross-sectional qualitative study, interviewing 113 providers at 36 public, private, and nongovernmental health facilities in Kenya, South Africa, and Zimbabwe that were offering PrEP during the research period or were likely to offer PrEP in the future. Data were coded in NVivo 11, and an applied thematic analysis was conducted.


Most providers preferred that adolescent girls wait until age 18 to have sex but acknowledged that many girls younger than 18 could benefit from oral PrEP. Their primary concern was whether adolescent girls would be able to take PrEP daily, especially if they do not tell their parents or partners they are using it. Providers reported that it was more challenging to deliver PrEP and other HIV services to girls younger than 18. Those with experience providing PrEP pointed to stigma and lack of PrEP awareness in communities as two primary barriers to PrEP uptake and use.


Providers were generally accepting of oral PrEP as an HIV prevention option for AGYW; however, many had negative attitudes about adolescent girls being sexually active and concerns about whether they could take PrEP daily. Results were used to update national PrEP training materials to address negative provider attitudes about PrEP use by AGYW.

Peer Review reports


Adolescent girls and young women (AGYW) in eastern and southern Africa are disproportionately affected by HIV. In 2016, AGYW accounted for 26 % of the regional HIV incidence, despite being only 10 % of the population [1]. Existing HIV prevention options — including male and female condoms, abstinence, limiting the number of sexual partners, knowing your partner’s HIV status, and antiretroviral therapy (ART) for HIV-positive partners — can be difficult for an adolescent girl or young woman to use because they require the cooperation of her male partner and prevailing gender norms hinder AGYW’s decision-making power and agency in relationships [2,3,4,5,6,7].

Oral pre-exposure prophylaxis (hereafter referred to as “PrEP”) has the potential to promote choice and control over HIV prevention because it can be used without a partner’s knowledge or consent [8,9,10]. In 2015, WHO recommended daily PrEP — in the form of a tablet containing emtricitabine/tenofovir disoproxil fumarate — for use by individuals at ongoing substantial risk of HIV [11]; by June 2021, it was being offered in 84 countries [12]. In Kenya, South Africa, Zimbabwe, and other countries in southern and eastern Africa, PrEP is recommended for high-risk AGYW subpopulations, such as those who engage in transactional and intergenerational sex, experience gender-based violence (GBV), have sexually transmitted infections (STIs), are married or have multiple sexual partners, have partner(s) of unknown HIV status, or have older sexual partners, as well as those who perceive themselves to be at risk of HIV acquisition [13,14,15,16,17]. PrEP can effectively protect AGYW from HIV if they are able to access and use it as instructed [18,19,20,21].

Health providers play a critical role in the uptake and effective use of sexual and reproductive health services [22,23,24,25,26]. Studies among health providers suggest that their knowledge, attitudes, and beliefs about PrEP and potential PrEP clients influence their willingness to offer it [27,28,29,30]; however, few published studies explore providers’ attitudes toward [31, 32] and experiences with delivering PrEP to AGYW. A better understanding of providers’ perceptions of PrEP use by AGYW is needed to identify potential barriers to delivery of PrEP to AGYW. In addition, the experiences of providers who are already delivering PrEP to AGYW can provide insights into barriers to PrEP uptake and use among AGYW and strategies for addressing those barriers.

The Optimizing Prevention Technology Introduction On Schedule (OPTIONS) Consortium is a project that provided technical assistance from 2015 to 2020 to countries rolling out oral PrEP, with a focus on AGYW. In Kenya, South Africa, and Zimbabwe, the OPTIONS Consortium provided support to national- and county-level PrEP technical working groups, which included national health officials and other key stakeholders responsible for introducing and scaling up PrEP. Among other activities, OPTIONS conducted surveys and follow-up in-depth interviews in 2017‒2018 with providers in the three countries — both those experienced in PrEP delivery (“PrEP-experienced”) and those who had not delivered PrEP (“PrEP-inexperienced”) — to understand providers’ attitudes toward and experiences with PrEP delivery to adolescent girls (ages 15 to 17) and young women (18 to 24).Footnote 1 Conducted in the early phases of PrEP rollout at the request of the PrEP technical working groups, this research was designed to be responsive to individual country needs, ultimately informing provider training and PrEP service delivery to AGYW in each country. The provider perspectives summarized in this paper identify attitudes and experiences that could also inform PrEP rollout to AGYW in other countries in sub-Saharan Africa.


Study setting

South Africa began PrEP rollout in 2016 using a phased approach that first targeted sex workers and then expanded to include men who have sex with men (MSM) in May 2017 and AGYW in October 2017. Zimbabwe also implemented a phased approach, starting in 2015 with nongovernmental organization (NGO) clinics, and then expanding to central, district, and clinic levels, respectively; AGYW were included as a priority population for PrEP from the beginning of rollout. Kenya took a different approach, rolling out PrEP nationally starting in 2017 and targeting a number of at-risk groups, including AGYW.

Study design

This qualitative study was conducted as part of a sequential explanatory design. An initial quantitative survey was conducted with 609 providers at 60 facilities to assess providers’ attitudes about PrEP for AGYW. The survey showed that some providers held attitudes indicating reservations about providing PrEP to AGYW (see Additional File 1) [33,34,35]. The qualitative study was used to interpret and clarify the results from the quantitative survey. Specifically, we sought to understand what providers’ primary concerns were so they could be addressed through training. In addition, we conducted in-depth interviews with providers at 36 public, private, and nongovernmental health facilities that were offering PrEP during the research period or were likely to offer PrEP in the future.


The survey responses were used to inform sampling for the qualitative study. One author (KR) created a continuous score based on responses to the attitudinal questions in the survey described above to inform sampling for the qualitative component. Questions had five-point Likert scale response options ranging from 1, “Strongly Agree,“ to 5, “Strongly Disagree.“ Negatively framed questions, such as, “It’s better to tell sexually active unmarried AGYW to abstain from sex rather than give her PrEP,“ were reverse-scored before creating the summary measure. The continuous score had a minimum value of 20 and maximum of 100, with higher values indicating more positive attitudes. Survey participants with the highest and lowest scores in each country were selected for in-depth interview (IDI) recruitment (extreme case sampling) [36]. We used this sampling approach to ensure we understood the extremes of providers’ attitudes about PrEP for AGYW. Additional IDI participants with high and low attitude scores were selected as needed to ensure representation of cadres, provinces/districts, facility types (public/private/nongovernmental and primary/secondary/tertiary), and sex (see Table 1).

Table 1 Summary of study site and participant selection by country

Country research teams chose sites and facilities for the in-depth interviews in collaboration with the ministries of health and PrEP technical working groups to ensure the research was responsive to individual country needs. For example, we sampled a mix of sites that were and were not offering PrEP in Zimbabwe because the national Ministry of Health and Child Care (MOHCC) was preparing for PrEP scale-up at the time of the study and was interested in understanding the attitudes of both PrEP-experienced and PrEP-inexperienced providers. Kenya was already providing PrEP nationally; based on the PrEP national research agenda, Ministry of Health (MOH) advisors wanted data from facilities providing PrEP to assess how services were being offered. Details on country-specific site and facility selection are provided in Table 1. Interviewed cadres included doctors, nurses, counselors, and community workers, selected because they have the most direct contact with PrEP clients.

Data collection

The research conformed to international ethical standards as stated in the United States Federal Policy for the Protection of Human Subjects and was approved by the Amref Health Africa Ethics and Scientific Review Committee in Kenya, the Medical Research Council of Zimbabwe, the Wits Human Research Ethics Committee in South Africa, and the FHI 360 Protection of Human Subjects Committee in the United States. All participants provided written informed consent before participating.

Experienced male and female qualitative data collectors trained in research methods and ethics and sensitized on the study protocol conducted interviews in the participant’s preferred language (English, Swahili, Kamba, or Dholuo in Kenya; English, isiXhosa, or Zulu in South Africa; and English, Shona, or Ndebele in Zimbabwe). The data collectors called survey participants who had agreed to be contacted for potential participation in an IDI and were selected using the extreme case sampling described above. Study participants did not know personal details about the data collectors and had no relationship with them prior to the study. If someone was not reached after three calls or if the survey participant refused to be interviewed, another survey participant who had agreed to be contacted for an IDI and fell within those selected by extreme case sampling was called. Interviews were scheduled with those who agreed to be interviewed. 5 % of participants who were contacted refused to participate due to various reasons, including no longer working at the target facility, refusing to be audio-recorded, being busy with other responsibilities, and being on leave. 12 % of participants could not be reached.

Data collection took place from July to October 2018. Trained interviewers explained the purpose of the interviews, consented participants, and conducted in-person IDIs in private locations convenient to participants where they could not be overheard. Interviews were audio-recorded. Some participants in Zimbabwe did not consent to be audio-recorded due to concerns regarding an upcoming election. For these interviews, data collectors were accompanied by a note-taker and paused frequently to ensure the note-takers were able to document the interviews near-verbatim. Participants in Zimbabwe and Kenya were reimbursed for their time in accordance with local standards.

Data collectors used a semi-structured interview guide (see Additional File 2), available in English and local languages, that covered experiences providing PrEP and other HIV services to AGYW and attitudes about acceptable ages of sexual debut and PrEP use for adolescents. The IDIs explored attitudes separately for adolescent girls and young women. The guide also included a vignette describing a fictional adolescent PrEP client (called “Tshepiso” in South Africa, “Tafadzwa” in Zimbabwe, and “Pendo” in Kenya, but hereafter referred to as “Pendo”), with follow-up questions about the best HIV prevention options for her, whether she should disclose PrEP use to her partner and parents, concerns about her using PrEP, and what support she would need to use PrEP successfully. Vignettes are used in qualitative research to explore participant’s attitudes and beliefs [37].

The interview guides were pilot tested in each country. The research team met weekly during data collection to discuss the status of recruitment and data collection; the data collectors confirmed that data saturation had been reached — meaning no new themes were emerging — when the planned number of interviews had been completed [38].

Data management and analysis

The data collectors simultaneously transcribed and translated the interviews into English, and then reviewed the transcripts for accuracy. In South Africa, the transcripts were also back translated and reviewed for accuracy by an external translation company. Data were coded and analyzed by the authors — including analysts from in the US and each country — using an applied thematic analysis approach [39]. Coding was conducted in NVivo 11 [40] using a codebook developed a priori based on the interview guide, with additional thematic codes added during the analysis process. The a priori codes were based on the survey results and the interview guide, both of which were informed by the experience of the co-authors’ organizations implementing PrEP services and literature on barriers to adolescents and young people accessing health services. Coding was conducted by country in teams of four to six analysts, who noted key differences by PrEP-experienced versus PrEP-inexperienced.

To assess inter-coder agreement, a team of eight analysts coded selected transcripts independently, compared coding, and resolved differences through discussion. Changes to the coding approach or codebook were documented, and previously coded transcripts were reviewed and updated for consistency. For each country, inter-coder agreement assessments continued until the coding team reached agreement of 80 % or higher [41].

Analysts ran code reports in NVivo Version 11 and reduced and organized the data into themes [36, 39]. After synthesizing the results across the three countries, analysts compared responses to select qualitative questions by providers with positive and negative attitude scores to assess any systematic differences.


Description of participants

We conducted 113 IDIs (Kenya = 40, South Africa = 46, and Zimbabwe = 27), which lasted 55 min on average. Participants included 78 providers with experience delivering PrEP and 35 without PrEP experience. The average age was 33 years and the majority (70 %) were female. Experienced PrEP providers primarily provided counseling and education on PrEP. Nearly two-thirds of IDI participants were community-based workers and nurses; 91 % had experience delivering health services to young women and 77 % to adolescent girls (see Table 2).

Table 2 Participant demographics

Attitudes toward and perceptions of PrEP for AGYW

By following up on potential barriers to PrEP provision that emerged from the survey results, the qualitative interviews provide a nuanced understanding of providers’ attitudes and perceptions of PrEP for AGYW. Results are summarized by interview topic below, and illustrative quotes are presented in Table 3. The results were similar across countries unless otherwise noted. Only a few minor differences emerged between PrEP-experienced and -inexperienced providers; a few PrEP-inexperienced providers showed a preference for AGYW using condoms over PrEP, and some shared concerns with AGYW ability to take PrEP daily. Similarities and differences between participants with positive and negative attitude scores from the survey are detailed at the end of this section.

Table 3 Illustrative quotes

Overall perception of PrEP for AGYW

Across the topics that were explored in IDIs, one-third of providers voiced one or more concerns or hesitations, but few expressed consistently negative attitudes or serious concerns throughout the interview. For example, a PrEP-experienced clinician in Kenya stated that PrEP was a good option for “Pendo,” the 17-year-old girl in the vignette, because, “she has fears that the boyfriend has several sexual partners,” but the clinician recommended that she first try to abstain from sex because “she is an adolescent. That means she can wait to get to the mature age.” When asked about offering Pendo PrEP, the clinician replied, “For now no, because you know these drugs are meant for preventive measures and they have to be used as prescribed. So, if there is any non-adherence issue, she is at risk of getting HIV.” However, the clinician also stated that they would be comfortable offering PrEP to Pendo if she were someone they knew: “I am not concerned about what the lady is using, my concern is about what she might get…we just want to prevent […] HIV.”

Acceptable age for sexual activity and PrEP use

Many providers said girls engaged in sexual activity at an earlier age than they thought was appropriate. The majority preferred that girls wait until they are 18. The reasons providers cited for this preference included that 18 is the age when girls typically complete secondary school, the legal age of consent in Zimbabwe and Kenya, and the age when young people become “more mature.” A few — mostly PrEP-inexperienced providers — felt strongly that ages 15 to 19 were “too young” for sex and that “sex could wait.”

Despite their concerns about adolescent girls being sexually active, IDI participants acknowledged that many adolescent girls need HIV prevention education, and those at risk of HIV could benefit from PrEP. Most IDI participants said that it is acceptable for AGYW to initiate PrEP when they are 15 to 19 years old or as soon as they are sexually active. Only a small minority of providers said 15 to 19 was “too young” to initiate PrEP, because they are “children” and should “study first.”

Best HIV prevention options

When providers were asked what they thought were the best HIV prevention options for Pendo, condoms and PrEP were mentioned most frequently, though few talked about using them simultaneously. They discussed the relative advantages and disadvantages of these methods, acknowledging that neither is perfect. They noted that condoms have the advantage of preventing HIV, other STIs, and pregnancy, while PrEP prevents only HIV. Condoms were also viewed as easier for young people to access and use. Providers said the main advantage of PrEP for Pendo was that she could use it without the knowledge or consent of her partner, in contrast to condoms, which would likely be challenging for her to negotiate. However, many acknowledged that PrEP use might be difficult to conceal from a partner, who might react negatively to its use. When asked which method they would recommend Pendo try first, most said condoms, because they provide protection against other STIs and pregnancy as well as HIV. In Zimbabwe, some responses varied by PrEP experience. A few providers, most of whom were PrEP-experienced, recommended that she try PrEP in conjunction with condoms, while the majority, who were largely PrEP-inexperienced, recommended she try condoms alone.

Concerns about PrEP

Participants’ primary concern with Pendo using PrEP was whether she would be able to adhere to daily use, especially if her partner or parents disapproved or if she was trying to use it without their knowledge. A small minority of providers were concerned about the potential for decreased condom use and increased risky behavior. They reasoned that once Pendo was on PrEP, “there is nothing she will be worried about.” They also pointed out that her partner might pressure her not to use condoms.

Despite their concerns, most providers said they would offer PrEP to Pendo because of her risk of HIV and potential difficulty negotiating the use of other HIV prevention methods. They said they “want her to be safe,” and that it is better to take PrEP than “leaving things to chance.” A few providers — mostly PrEP-inexperienced — were opposed to offering Pendo PrEP, primarily because of concerns about her ability to adhere to daily use.

Participants were asked if their responses would change if Pendo were someone they knew. Most said they would still provide PrEP to someone they knew, saying they would have “no problem” or would be “very happy,” because it would be better for her to use PrEP than to be at risk of HIV. Others had concerns about her being sexually active at “such an early age” and acknowledged the disconnect between how they felt as health providers and how they felt as parents.

Male partners

Participants said that the decision of whether to disclose PrEP use to a male partner was complex. Those who thought Pendo should disclose PrEP use to her partner said disclosure could facilitate adherence and continuation. She would not have to worry about hiding her PrEP use, and her partner could remind her to take PrEP daily or help her get refills. Others stated that disclosure was important to ensuring trust and transparency in her relationship. Many providers, especially in Kenya, stated that disclosure might encourage her partner to get tested or start using PrEP himself.

Several participants thought Pendo’s decision should be based on how much negotiating power she has in the relationship and how she thinks her partner will react, particularly whether he might react violently. Participants reasoned he might misunderstand her PrEP use to indicate that she does not trust him, has other partners, or is HIV-positive. Some providers in South Africa viewed PrEP use as an individual decision more than a relational one, calling it “a personal thing” that her partner “doesn’t have to know about,” and saying that “it’s her life.” Providers recommended that Pendo gauge her partner’s potential reaction by bringing up HIV testing and prevention generally, or that she use partner and/or couples’ HIV counseling and testing services to facilitate disclosure of PrEP use.


Participants were asked about Pendo disclosing PrEP use to parents. One-third to one-half of participants in each country said Pendo should disclose to her parents because they could provide encouragement and could support her adhering to daily use, obtaining PrEP refills, and managing side effects. Those who thought she should not disclose to her parents said there was “no need” or thought her parents would not react well. Disclosure would reveal that Pendo is sexually active, which her parents might not approve of; some even said that telling her parents would “destroy the relationship.” They also said parents may not understand what PrEP is because of low community awareness about it, including mistaking PrEP for ART. Even providers who thought Pendo should disclose noted that disclosure could be challenging for these same reasons.

Some providers said Pendo should decide whether to disclose based on the nature of her relationship with her parents. For example, if her parents were “modern,” “open-minded,” or “understanding,” she could talk to them about her PrEP use, but if they were “strict” it would be better not to discuss PrEP with them. A few providers in Zimbabwe had specific recommendations, such as suggesting that Pendo talk to her mother more generally about PrEP first, to gauge her reaction, or involve a counselor in the discussion.

Differences between participants with positive and negative attitudinal scores

For some IDI questions, participants’ responses aligned with their categorization of having positive or negative scores from the survey. For example, providers with positive attitudes from the survey tended to show more accepting attitudes in the IDIs regarding initiating PrEP at younger ages compared to those with negative scores who more often reported in IDIs that they thought adolescent girls should wait until they are 18 or older to have sex. Providers with negative attitudes from the survey most often recommended in IDIs that Pendo try condoms and abstinence or end the relationship. Providers with positive attitudes from the survey more often expressed that PrEP was a good option for Pendo.

For other IDI questions, there were no differences between providers with positive and negative attitude scores from the survey. Both extremes shared similar types of concerns about PrEP, and they expressed similar opinions about offering PrEP to someone they knew.

Experiences delivering PrEP and other HIV services to AGYW

Service delivery to AG versus YW

Reflecting on their experiences providing PrEP and other HIV services, providers across the three countries reported that they faced more challenges delivering services to adolescent girls compared with young women. They characterised adolescent girls as “troublesome,” “not listening,” “reluctant” to seek services or receive information, “clueless” about their partners’ behavior and “dishonest.” By comparison, they described young women as “more mature,” “focused,” willing to talk about sex and to “listen more,” and knowing how to “take care of themselves.”

These perceptions were attributed to the difference in life stages. Providers noted that young women live on their own or are married with children, which gives them more freedom to seek services and increased motivation to continue taking PrEP, whereas adolescents are more likely to live at home and be in school, which poses challenges of parental involvement and reduced mobility and access to services. Providers also said age differences can make it challenging for them to relate to adolescent girls. They suggested that adolescent girls may feel more comfortable discussing sensitive topics with peers or younger health workers.

Uptake, adherence, and continuation challenges

IDI participants with experience providing PrEP confirmed that uptake, adherence, and continuation among AGYW have been challenging, particularly for adolescent girls. They cited lack of PrEP awareness, stigma, and lack of PrEP disclosure to partners and parents as the primary barriers. Some also mentioned side effects as a barrier to PrEP use.

PrEP-experienced providers said PrEP awareness is low among AGYW and communities; most notable is the lack of understanding about the differences among PrEP, post-exposure prophylaxis (PEP), and ART. They also talked about the difficulties AGYW experienced using PrEP without telling their partners and parents. Lack of awareness about PrEP in the community and fear of negative reactions were cited as the primary reasons for not disclosing PrEP use to partners and parents. Providers reported that some parents received specific information about PrEP that helped garner their support and were then able to facilitate their daughters’ PrEP adherence.

Providers talked about two types of stigma as barriers to PrEP uptake and use: HIV stigma and stigma related to being sexually active. They said AGYW are concerned that community members who see a young woman access PrEP service will assume she is taking antiretroviral pills because she is HIV-positive. They also worry about parents or partners discovering the tablets or hearing them rattle in the bottle. Providers explained that adolescents feared being stigmatized if they used PrEP or accessed other HIV services, because that would mark them as someone who is sexually active, and they would be labeled “promiscuous” or assumed to be engaged in sex work. Providers said AGYW clients did not report experiencing stigma related to PrEP use, but their fear of being stigmatized was an important influence on their service-seeking behavior. Providers discussed HIV stigma as an issue that affected adolescent girls more than young women.

Service delivery strategies

PrEP providers shared strategies they were using to facilitate PrEP uptake, adherence, and continuation, including intensified counseling to address adherence and continuation challenges; community discussions to address stigma and normalize PrEP for AGYW; and peer support groups to encourage adolescent girls to share their challenges. They also track missed client visits and follow up with calls, SMS, and home visits to promote continuation. Providers discussed strategies used in other HIV services that could be applied to PrEP, including using social media and digital platforms to reach AGYW; supporting AGYW‒parent relationships through counseling, assisted disclosure, and health talks with parents; encouraging couples’ HIV testing and counseling; structuring services to improve anonymity and confidentiality; and providing services at places and times convenient for students.


Providers in this study were generally supportive of PrEP for AGYW, regardless of their experience providing PrEP. They had more reservations about PrEP use among adolescent girls compared to young women, rooted in (1) negative attitudes about adolescent girls being sexually active and (2) concern about the ability of AG to adhere to daily use, particularly when using PrEP without disclosing to parents and partners. These concerns are consistent with other studies of provider attitudes toward PrEP use among adolescent girls [27, 31]. A study with community gatekeepers in South Africa before PrEP was rolled out to AGYW found “moral anxiety about youth sexuality” as a main theme, and health providers talked about their role in “guardianship of adolescent sexuality” [32].

Participant concerns about adherence are supported by data from trials and national programs, which show that younger age is associated with lower adherence and continuation [42, 43]. PrEP-experienced providers in the study suggested that AGYW could be supported to use PrEP effectively through peer support groups, social media and digital platforms, and relationship counseling with parents and partners. These and other promising approaches — weekly communication from providers, integration of PrEP delivery into comprehensive sexual health programs, and cash incentives [42, 44,45,46,47,48] — should be evaluated with AGYW for effectiveness and feasibility.

Despite the concerns and challenges that providers in this study identified about delivering PrEP to adolescent girls, most acknowledged that adolescent girls could benefit from PrEP because of their risk of HIV and inability to negotiate condoms, including participants with negative attitude scores based on their responses to the quantitative survey. Further, most said they would be willing to offer PrEP to adolescent girls. Providers’ stated recognition of AG’s need for additional HIV prevention methods and their willingness to provide it are encouraging, though additional research on whether and how this willingness translates to actual service provision would be useful.

Consistent with other studies [27, 32, 44, 45, 49,50,51,52,53,54], participants reported that the main barriers to PrEP uptake and use among AGYW were lack of PrEP awareness among AGYW and communities; fear of disclosing PrEP use to partners and parents; and stigma related to HIV and to adolescent sexuality. These results suggest that intensive community sensitization to promote PrEP awareness, combat stigma, and address social norms around adolescent sexuality [32, 42, 51, 52, 55] is critical to making PrEP a viable HIV prevention option for AGYW and other vulnerable populations. Specific messages and events for parents, male partners, and community leaders could promote awareness, provide accurate information about PrEP, and help AGYW who want to use PrEP gain the support of their parents and partners. At the same time, building the skills and efficacy of stigmatized groups to challenge stigma has been identified as a best practice [56]; training AGYW to be PrEP ambassadors in their communities could help reduce PrEP stigma and promote AGYW PrEP use [57]. Finally, promoting PrEP as a method for anyone who wants to promote wellness, rather than a method for high-risk — and often highly stigmatized — groups, could help reduce stigma [45, 58,59,60].

Research utilization

Findings from this study have influenced provider training in the study countries. OPTIONS developed an AGYW Provider Training Package that included values clarification exercises to address specific negative attitudes revealed in the study and promote youth- and adolescent-friendly PrEP services [61]. These values clarification exercises were incorporated by the MOHCC in Zimbabwe into national PrEP provider trainings. In Kenya, the National PrEP Curriculum was updated to include the vignette used in this study. In South Africa, study findings informed the revision of the national PrEP service provider training to address emerging concerns regarding PrEP provision to adolescent girls.

Study results also informed the development of an HIV Prevention Ambassador Training Curriculum for Adolescent Girls and Young Women [62], which prepares AGYW ambassadors to support their peers to learn about PrEP as part of combination HIV prevention and to support peers who decide to use PrEP. To address the barriers to AGYW PrEP use that providers raised in this study, we included tools to help AGYW develop skills to talk with their parents and partners about PrEP and address community misconceptions about PrEP. The curriculum has been used to train ambassadors in Kenya, South Africa, and Zimbabwe, and these ambassadors have supported PrEP community awareness campaigns in Chitungwiza, Zimbabwe, and Kiambu County, Kenya.


Providers’ attitudes about PrEP for AGYW were self-reported and may not be entirely accurate given the likelihood of implicit bias. Barriers to PrEP uptake, adherence, and continuation were reported from the point of view of providers and may not fully reflect clients’ experiences. In addition, data collection occurred when the three countries were in the early stages of national PrEP rollout; it is possible provider perspectives have evolved with experience and as additional provider training and community awareness campaigns have been conducted.

Another limitation of this study is that the samples differ by country, because the sampling approach for each country was designed to be directly responsive to in-country needs and priorities and was not designed for forming cross-country comparisons. During country-specific analyses, similar themes emerged across countries, leading to the decision to report the multi-country findings together. Although we noted results that emerged from a specific country, we were unable to systematically compare results across countries because of the difference in samples by country. Nonetheless, the convergent results point to important issues that could be addressed to improve PrEP service delivery for AGYW. These results could be used to inform future research that could investigate differences in providers’ attitudes based on provider age, PrEP experience, cadre, or gender or explore to what extent provider attitudes were shaped by country-level differences in culture, policy, or PrEP rollout strategy.


In summary, providers who participated in this research were generally accepting of PrEP as an HIV prevention option for adolescent girls and young women though many had negative attitudes about adolescent girls being sexually active. They also had concerns about whether adolescent girls could take PrEP daily, particularly given the lack of PrEP awareness in the community and the challenges of disclosing PrEP use to parents and partners. To promote effective delivery of PrEP for AGYW, national PrEP provider training in Kenya, South Africa, and Zimbabwe was updated to address negative attitudes about adolescent sexual activity and concerns about PrEP. In addition, a training curriculum for AGYW HIV prevention ambassadors was created to address potential barriers to PrEP use identified in this study. These findings could inform the introduction and scale-up of PrEP for AGYW in other countries and potential future introduction of new ARV-based HIV prevention methods such as the dapivirine ring and injectable PrEP.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available due to potential sensitivity of the content but are available from the corresponding author on reasonable request.


  1. In Kenya, “adolescent girls” were defined as ages 15‒19 and “young women” as 20‒24, per national standards.



Adolescent girls and young women


Antiretroviral therapy


Gender-based violence


Men who have sex with men


Ministry of Health and Child Care


Nongovernmental organization


Optimizing Prevention Technology Introduction On Schedule


Post-exposure prophylaxis


Pre-exposure prophylaxis


President's Emergency Plan for AIDS Relief


Sexually transmitted infections


U.S. Agency for International Development


  1. UNAIDS. Ending AIDS: progress towards the 90-90-90 targets. Geneva: UNAIDS; 2017.

    Google Scholar 

  2. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS. 1997;10(Suppl 3):43–51.

    Google Scholar 

  3. Raphael MC. Microbicides are promoted as offering a ‘female-controlled’ HIV prevention method: so can they revolutionize the HIV crisis of young women in Kenya? J Public Health. 2012;34(4):625–30.

    Article  Google Scholar 

  4. Saul J, Moore J, Murphy ST, Miller LC. Relationship violence and women’s reactions to male- and female-controlled HIV prevention methods. AIDS Behav. 2004;8(2):207–14.

  5. Marcus R, Page E. Changing discriminatory norms affecting adolescent girls through communication activities: a review of evidence. London: Overseas Development Institute; 2014. Accessed 21 Sept 2020.

  6. Muralidharan A, Fehringer J, Pappa S, Rottach E, Das M, Mandal M. Transforming gender norms, roles, and power dynamics for better health: evidence from a systematic review of gender-integrated health programs in low- and middle-income countries. Washington (DC): Futures Group, Health Policy Project; 2015. Accessed 21 Sep 2020.

  7. World Health Organization (WHO). Promoting gender equality to prevent violence against women. Geneva: WHO; 2009. Accessed 21 Sep 2020.

  8. Braksmajer A, Senn TE, McMahon J. The potential of pre-exposure prophylaxis for women in violent relationships. AIDS Patient Care STDS. 2016;30(6):274–81.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Heffron R, Pintye J, Matthews LT, Weber S, Mugo N. PrEP as peri-conception HIV prevention for women and men. Curr HIV/AIDS Rep. 2016;13(3):131–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Aaron E, Blum C, Seidman D, Hoyt MJ, Simone J, Sullivan M, et al. Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care STDS. 2018;32(1):16–23.

  11. World Health Organization (WHO). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: WHO; 2018.

    Google Scholar 

  12. AVAC. [Internet]. New York: AVAC; 2020. Accessed 25 June 2021.

  13. Birdthistle I, Schaffnit SB, Kwaro D, Shahmanesh M, Ziraba A, Kabiru CW, et al. Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol. BMC Public Health. 2018;18(1):912.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Dunbar MS, Kripke K, Haberer J, Castor D, Dala S, Mukoma W, et al. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa. Sexual Health. 2018;15(6):513–21.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Celum CL, Delany-Moretlwe S, McConnell M, van Rooyen H, Bekker LG, Kurth A, et al. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. J Int AIDS Soc. 2015;18(4Suppl 3):20227.

    Article  PubMed  PubMed Central  Google Scholar 

  16. The Global Fund. The Global Fund measurement framework for adolescent girls and young women programs. Geneva: The Global Fund; 2018.

    Google Scholar 

  17. Pilgrim N, Mathur S, Gottert A, Rutenberg N, Pulerwitz J. Building evidence to guide PrEP introduction for adolescent girls and young women. Washington (DC): Population Council; 2016.

    Book  Google Scholar 

  18. ATHENA Initiative. A review of the pre-exposure prophylaxis (PrEP) research and evidence landscape in Kenya and Uganda for adolescent girls and young women. Washington (DC): JSI Research & Training Institute; 2017.

    Google Scholar 

  19. The Global Fund. Adolescent girls and young women in high-HIV burden settings. Geneva: The Global Fund; 2017.

    Google Scholar 

  20. Kirby T. Targeting HIV prevention to young women in Africa. The Lancet. 2016;388(10060):2579.

    Article  Google Scholar 

  21. Pulerwitz J. HIV Prevention in the hands of adolescent girls and young women: acceptability and feasibility of oral PrEP in Tanzania. New York: The Population Council; 2018.

    Google Scholar 

  22. Glinski A, Sexton M, Petroni S. Understanding the adolescent family planning evidence base. Washington [DC]: International Center for Research on Women; 2014.

    Google Scholar 

  23. Singh NS, Aryansinghe SA, Smith J, Khosla R, Say L, Blanchet K. A long way to go: a systematic review to assess the utilisation of sexual and reproductive health services during humanitarian crises. BMJ Global Health. 2018;3(2):000682.

    Article  Google Scholar 

  24. Bolton L, Bradford C. Adolescent sexual and reproductive health. Oxford: HEART; 2016.

    Google Scholar 

  25. Dassah CW, Cornelius AT, Edward T. Determinants of contraceptive use and future contraceptive intentions of women attending child welfare clinics in urban Ghana. BMC Public Health. 2017;18(1):79.

    PubMed  PubMed Central  Google Scholar 

  26. FHI 360. Examining the influence of providers on contraceptive uptake in Rwanda. Durham (NC): FHI 360; 2013.

    Google Scholar 

  27. Pilgrim N, Jani N, Mathur S, et al. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: the role of provider biases and quality of care. PLoS One. 2018;13(4):132018.

    Article  CAS  Google Scholar 

  28. Castel AD, Feaster DJ, Tang W, Willis S, Jordan H, Villamizar K, et al. Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. J Acquir Immune Defic Syndr. 2015;70(5):520–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Mathur S, Pilgrim N, Pulerwitz J. PrEP introduction for adolescent girls and young women. Lancet HIV. 2016;3(9):e406-e8.

    Article  Google Scholar 

  30. Ross I, Mejia C, Melendez J, Chan PA, Nunn AC, Powderly W, et al. Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: implications for country-wide implementation. PloS One. 2017;12(3):e0173057.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Mullins TLK, Idoine CR, Zimet GD, Kahn JA. Primary care physician attitudes and intentions toward the use of HIV pre-exposure prophylaxis in adolescents in one metropolitan region. J Adolescent Health. 2019;64(5):581–81.

  32. Nakasone SE, Chimbindi N, Mthiyane N, Nkosi B, Zuma T, Baisley K, et al. “They have this not care–don’t care attitude:” A mixed methods study evaluating community readiness for oral PrEP in adolescent girls and young women in a rural area of South Africa. AIDS Res Ther. 2020;17(1):55.

  33. Nhamo D, Stankevitz K, Mahaka I, Ncube G, Bhatarasa T, Makahamadze N, et al. Health care workers’ knowledge, attitudes, and practices related to oral PrEP provision to adolescent girls and young women in Zimbabwe. HIV Research for Prevention Conference; 2018 Oct 21–25.

  34. Murire M, Shamu P, Pillay D, Lanham M, Ridgeway K, Shoko N, et al. Understanding service providers’ knowledge of oral PrEP and attitudes toward provision to populations at substantial HIV risk in South Africa. HIV Research for Prevention Conference; 2018 Oct 21–25.

  35. Mireku M, Kyongo J, Stankevitz K, Jeckonia P, Ikahu A, Otiso L, et al. Health care providers’ knowledge, attitudes and practices towards provision of PrEP to adolescent girls and young women in Kenya. HIV Research for Prevention Conference; 2018 Oct 21–25.

  36. Tolley EE, Ulin PR, Mack N, Robinson ET, Succop SM. Qualitative methods in public health: a field guide for applied research. 2nd ed. San Francisco: Jossey-Bass Public Health; 2016.

    Google Scholar 

  37. Finch J. The vignette technique in survey research. Sociology. 1987;21(1):105–14.

    Article  Google Scholar 

  38. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.

    Article  Google Scholar 

  39. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks (CA): Sage Publications, Inc.; 2011.

    Google Scholar 

  40. QSR International. Ltd QIP. NVivo qualitative data analysis software. Version 11. 2018.

  41. Holsti OR. Content analysis for the social sciences and humanities. Reading (MA): Addison-Wesley; 1969.

    Google Scholar 

  42. Buchbinder SP, Liu AY. CROI 2019: advances in HIV prevention and plans to end the epidemic. Top Antivir Med. 2019;27(1):8.

    PubMed  PubMed Central  Google Scholar 

  43. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Sidebottom D, Ekström AM, Strömdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV–how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, et al. HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22(Suppl 4):e25298.

    PubMed  PubMed Central  Google Scholar 

  46. Hartmann M, Lanham M, Palanee-Phillips T, Mathebula F, Tolley EE, Peacock D, et al. Generating CHARISMA: development of an intervention to help women build agency and safety in their relationships while using PrEP for HIV prevention. AIDS Educ Prev. 2019;31(5):433–51.

  47. Sharpe JD, Kamara MT. A systematic evaluation of mobile apps to improve the uptake of and adherence to HIV pre-exposure prophylaxis. Sex Health. 2018;15(6):587–94.

    Article  PubMed  Google Scholar 

  48. Hosek S, Celum C, Wilson CM, Kapogiannis B, Delany-Moretlwe S, Bekker L-G. Prevention HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa. J Int AIDS Soc. 2016;19(Suppl 6):21107.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Chimbindi N, Mthiyane N, Zuma T, Baisley K, Pillay D, McGrath N, et al. Antiretroviral therapy based HIV prevention targeting young women who sell sex: a mixed method approach to understand the implementation of PrEP in a rural area of KwaZulu-Natal, South Africa. AIDS Care. 2021;23:1–9.

  50. Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada whores”. Am Journal Public Health. 2015;105(10):1960–4.

    Article  Google Scholar 

  51. Kambutse I, Igiraneza G, Ogbuagu O. Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda. PloS One. 2018;13(11):e0207650.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Maxwell S, Gafos M, Shahmanesh M. Pre-exposure prophylaxis use and medication adherence among men who have sex with men: a systematic review of the literature. J Assoc Nurses AIDS Care. 2019;30(4):e38–61.

    Article  PubMed  Google Scholar 

  53. Bradley E, Forsberg K, Betts JE, DeLuca JB, Kamitami E, Porter SE, et al. Factors affecting pre-exposure prophylaxis implementation for women in the United States: a systematic review. J Women’s Health (Lrchmt). 2019;28(9):1272–85.

    Article  Google Scholar 

  54. Digolo L, Ochieng C, Ngunjiri A, Kiragu M, Kyongo J, Otiso L, et al. Uptake of and retention on HIV pre-exposure prophylaxis (PrEP) among adolescent girls and young women in Kenya. 8th International Workshop on HIV & Women; The Colonnade Hotel, Boston: LVCT Health; 2018.

  55. Moskowitz DA, Macapagal K, Mongrella M, Pérez-Cardona L, Newcomb ME, Mustanski B. What if my dad finds out!?: Assessing adolescent men who have sex with men’s perceptions about parents as barriers to PrEP uptake. AIDS Behav. 2020;24(9):2703–19.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Mc Lean R, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17(1):1–15.

    Article  Google Scholar 

  57. Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS Soc. 2020;23(3):25463.

  58. Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV-AIDS Rep. 2018;15(2):190–97.

    Article  Google Scholar 

  59. Stankevitz K, Schwartz K, Hoke T, Li Y, Lanham M, Mahaka I, et al. Reaching at-risk women for PrEP delivery: what can we learn from clinical trials in sub-Saharan Africa? PloS One. 2019;14(6):e0218556.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Amico KR, Ramirez C, Caplan MR, Montgomery BE, Stewart J, Hodder S, et al. Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions. J Intl AIDS Soc. 2019;22(3):e25247.

    Article  Google Scholar 

  61. OPTIONS Consortium. Provider training package: effective oral PrEP delivery for adolescent girls and young women. Washington (DC): OPTIONS Consortium; 2019. Accessed 21 Sep 2020.

  62. OPTIONS Consortium. OPTIONS HIV prevention ambassador training package Durham (NC): FHI 360; 2019. Available from:

Download references


OPTIONS Consortium Research Team (in alphabetical order): Taurai Bhatasara, Lina Digolo, Theresa Hoke, Annrita Ikahu, Patriciah Jeckonia, Jordan Kyongo, Michele Lanham, Megan Lydon, Nicole Makahamadze, Maryline Mireku, Wanjiru Mukoma, Saiqa Mullick, Mercy Murire, Joseph Murungu, Getrude Ncube, Definite Nhamo, Christian Ochieng, Diantha Pillay, Subarna Pradhan, Kathleen Ridgeway, Katie Schwartz, Patience Shamu, and Kayla Stankevitz.

The authors would like to thank the study participants and data collectors. We would also like to acknowledge the South Africa National Department of Health, the Zimbabwe Ministry of Health and Child Care, the Kenya National AIDS and STI Control Programme, and the county health management teams in Nairobi, Kisumu, Homabay, and Kitui counties for their support of this research.


This program is made possible by the generous assistance from the American people through the United States Agency for International Development (USAID) in partnership with President’s Emergency Plan for AIDS Relief (PEPFAR) (Cooperative Agreement No. AID-OAA-A-15-00035) and by the Prevention Market Manager project, funded by the Bill & Melinda Gates Foundation. The contents do not necessarily reflect the views of the funders or the United States Government.

Author information

Authors and Affiliations




ML, KR, MM, DN, DP, MMu, KS, JK, and SM conceptualized and designed the studies. MM, DF, DP, MMu, and JK collected the data. ML, KR, MM, DN, and MMu analyzed the qualitative data. ML, MM, and KR wrote the paper. DN, DP, MMu, KS, JK, and SM reviewed and edited the manuscript. All authors have read and approved the final version.

Corresponding author

Correspondence to Michele Lanham.

Ethics declarations

Ethics approval and consent to participate

The research conformed to international ethical standards as stated in the United States Federal Policy for the Protection of Human Subjects and was approved by the Amref Health Africa Ethics and Scientific Review Committee in Kenya, the Medical Research Council of Zimbabwe, the Wits Human Research Ethics Committee in South Africa, and the FHI 360 Protection of Human Subjects Committee in the United States. All participants provided written informed consent before participating.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

 Survey responses about PrEP for AGYW by country. Survey responses to attitudinal questions about acceptability of PrEP for AGYW, reported by country 

Additional file 2:

 Interview Guide Questions about PrEP for AGYW. Interview questions developed for this study to assess providers’ attitudes about PrEP for AGYW and experiences delivering PrEP to AGYW 

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lanham, M., Ridgeway, K., Mireku, M. et al. Health care providers’ attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe. BMC Health Serv Res 21, 1112 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: